BIONIK LABORATORIES CORP. Deferred Tax Assets, Net of Valuation Allowance
BIONIK LABORATORIES CORP. had Deferred Tax Assets, Net of Valuation Allowance of $16.43 million as of 2023-03-31, per its 10-K filed 2023-06-21.
Discontinued › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Components of Deferred Tax Assets › Deferred Tax Assets, Net › Deferred Tax Assets, Net of Valuation Allowance
us-gaap:DeferredTaxAssetsNet · last filed 2023-06-21
- 2023-03-31: Deferred Tax Assets, Net of Valuation Allowance $16.43M.
- 2022-03-31: Deferred Tax Assets, Net of Valuation Allowance $15.81M.
- 2021-03-31: Deferred Tax Assets, Net of Valuation Allowance $15.42M.
- 2020-03-31: Deferred Tax Assets, Net of Valuation Allowance $12.35M.
| Period end | Deferred Tax Assets, Net of Valuation Allowance |
|---|---|
| 2023-03-31 | $16.43M 10-K · filed 2023-06-21 |
| 2022-03-31 | $15.81M 10-K · filed 2023-06-21 |
| 2021-03-31 | $15.42M 10-K · filed 2022-06-09 |
| 2020-03-31 | $12.35M 10-K · filed 2021-06-24 |
| 2019-03-31 | $9.50M 10-K · filed 2020-06-29 |
| 2018-03-31 | $7.02M 10-K · filed 2019-07-01 |
| 2017-03-31 | $5.96M 10-K · filed 2018-06-27 |
| 2016-03-31 | $2.85M 8-K · filed 2017-12-21 |
| 2015-12-31 | $1.99M 10-KT · filed 2016-06-30 |
| 2015-03-31 | $1.20M 10-KT · filed 2016-06-30 |
| 2014-12-31 | $1.04M 10-KT · filed 2016-06-30 |
| 2014-03-31 | $579.93K 10-KT · filed 2015-05-27 |
| 2013-12-31 | $7.00K 10-K · filed 2014-04-15 |
| 2013-03-31 | $337.18K 10-KT · filed 2015-05-27 |
| 2012-12-31 | $4.40K 10-K · filed 2014-04-15 |
| 2011-12-31 | $2.50K 10-K · filed 2013-03-06 |